ArticleJournal of cancer research and clinical oncology2017

Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia.

Qian Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.